Stock Events

Stock Events

NetraMark 

C$0.7000
16
+C$0.00+0% 17:38 Today

Statistics

Day High
0.7
Day Low
0.68
52W High
1.65
52W Low
0.59
Volume
9,675
Avg. Volume
35,690
Mkt Cap
66.24M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-1,208.56%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
432,000Revenue
-5.22MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIAI.TO. It's not an investment recommendation.
Amazon
2
AMZN
Alphabet
2
GOOG
Ethereum
2
ETH.CRYPTO
YieldMax MSTR Option Income Strategy
2
MSTY

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a major player in the pharmaceutical industry, directly competing with NetraMark in drug development and personalized medicine.
Novartis
NVS
Mkt Cap304.1B
Novartis is involved in advanced pharmaceuticals and personalized healthcare solutions, overlapping with NetraMark's focus areas.
Merck
MRK
Mkt Cap370.89B
Merck operates in the pharmaceutical sector, focusing on innovative therapies that compete with NetraMark's offerings.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly is a leader in pharmaceuticals, particularly in areas that utilize AI for drug discovery, similar to NetraMark's approach.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline focuses on research in pharmaceuticals, competing with NetraMark in the development of new drugs and health solutions.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie works in biopharmaceuticals, directly competing with NetraMark in therapeutic areas and personalized medicine.
AMGEN
AMGN
Mkt Cap236.38B
Amgen specializes in biotechnological medicines, which aligns with NetraMark's focus on innovative healthcare solutions.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol-Myers Squibb is a major biopharma company, competing in the same space as NetraMark with a focus on serious diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals focuses on genetic and biomarker-driven drug development, similar to NetraMark's AI-driven approach.
Vertex Pharmaceuticals
VRTX
Mkt Cap138.42B
Vertex Pharmaceuticals is known for its scientific innovations in healthcare, competing with NetraMark in drug discovery and development.

About

Nurosene Health Inc. operates as a Canadian, technology-focused wellness company, primarily engaged in formulating its own distinctive range of nutraceutical products. Its offerings include Nuro Drive, designed to enhance physical stamina and mental acuity, and Nuro Restore, which aims to improve sleep quality while alleviating stress, pain, and inflammation. Beyond its product lines, Nurosene is also developing a mobile application for virtual care, intended to offer continuous assistance to individuals managing mental health challenges. The company was founded in 2019 and operates from its headquarters in Toronto, Canada.
Show more...
CEO
Mr. George Achilleos
Country
Canada
ISIN
CA64119M1059
WKN
000A3D5X9

Listings

STU
DE
PF0.STU
MU
DE
PF0.MU
CN
CA
MEND.CN
OTC Link
US
AINMF

0 Comments

Share your thoughts

FAQ

What is NetraMark stock price today?▼
The current price of AIAI.TO is C$0.70 CAD — it has increased by +0% in the past 24 hours. Watch NetraMark stock price performance more closely on the chart.
What is NetraMark stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Toronto Exchange exchange NetraMark stocks are traded under the ticker AIAI.TO.
What is NetraMark market cap?▼
Today NetraMark has the market capitalization of 66.24M
What is NetraMark revenue for the last year?▼
NetraMark revenue for the last year amounts to 432,000 CAD.
What is NetraMark net income for the last year?▼
AIAI.TO net income for the last year is -5.22M CAD.
In which sector is NetraMark located?▼
NetraMark operates in the Other sector.
When did NetraMark complete a stock split?▼
NetraMark has not had any recent stock splits.
Where is NetraMark headquartered?▼
NetraMark is headquartered in Toronto, Canada.